Space startup Varda raises $187 million in funding to make drugs in orbit

Space startup Varda raises 7 million in funding to make drugs in orbit


Pavlo Gonchar | Lightrocket | Getty Images

Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space.

The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. It brought the total capital Varda’s raised to $329 million.

“By expanding, we can support work on more complex molecules and ultimately increase cadence to achieve the turnaround times the pharmaceutical industry expects,” Chief Science Officer Adrian Radocea said in a press release Thursday.

Varda’s main mission is to launch and return drugs made in space. The startup has said the medicines crystallize differently in orbit due to the gravity differences, which would allow it to complete drugs that are currently difficult to manufacture.

In 2024, the space startup’s W-Series 1 capsule received FAA approval to return after successfully creating the drug Ritonavir the previous year.

So far, Varda said the company has been able to complete three space launches. Now, a fourth is in orbit, and the company expects to launch a fifth by the end of the year. Varda’s system uses Rocket Lab’s Photon spacecraft for its operation and adds its manufacturing module and a heatshield-protected capsule.

“With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world’s first microgravity-enabled drug formulation,” said Varda CEO Will Bruey.

Varda Space Industries is the first company to process materials outside the International Space Station.

Recently, the space company has also operated a testbed for the U.S. government to use the W-series reentry vehicles to advance technology.

Varda said it has expanded into Huntsville, Alaska, and opened a laboratory in El Segundo, California, to begin work to crystallize more drugs.

“Our new lab space is an investment in our belief that in-space pharmaceutical manufacturing will drive the foundation of the orbital economy,” Radocea said.



Source

Shares of American Eagle surge after Trump calls Sydney Sweeney campaign ‘hottest ad out there’
Business

Shares of American Eagle surge after Trump calls Sydney Sweeney campaign ‘hottest ad out there’

A window display of actress Sydney Sweeney is seen on a window of an American Eagle store on August 01, 2025 in New York City. Michael M. Santiago | Getty Images Shares of American Eagle surged more than 15% on Monday after President Donald Trump complimented the retailer’s marketing campaign with actress Sydney Sweeney. “Sydney […]

Read More
More than 3,000 Boeing defense workers go on strike after rejecting contract
Business

More than 3,000 Boeing defense workers go on strike after rejecting contract

A worker performs quality checks on a Boeing Co. F/A-18 Super Hornet fighter aircraft at the Boeing Defense, Space & Security facility in St. Louis, Missouri, U.S., on Monday, July 24, 2018. Alex Flynn | Bloomberg | Getty Images Some 3,200 Boeing defense unit workers went on strike early Monday hours after turning down a […]

Read More
New guide to wealth terminology aims to ‘counteract some of the BS’ for investors
Business

New guide to wealth terminology aims to ‘counteract some of the BS’ for investors

Senior woman looking on cell phone at sidewalk cafe. Yuliya Taba | E+ | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. A leading advisory group to the wealth […]

Read More